Among biological products, a distinction is made between cell products used for therapeutic purposes, innovative therapy medicines (gene therapy and cell therapy), labile blood products, as well as tissues or organs of human or animal origin. Depending on their characteristics, intended use, mode of production or their nature and origin, they are not all subject to the same rules. As such, ANSM is involved at different levels and in a coordination capacity with several health authorities.
